Back to search

Article

The Future of Targeted Treatment of Primary Sjögren's Syndrome: A Focus on Extra-Glandular Pathology

2022-10-19

Abstract excerpt

Primary Sjögren's syndrome (pSS) is a chronic, systemic autoimmune disease defined as exocrine gland hypofunction resulting in dry eyes and dry mouth. Recent interest in biological therapies for pSS has been garnered, however achieving FDA-approval has been challenging due to the numerous complications in the trials. Current literature lacks insight and a molecular target-based approach to the development of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9eaf1ff2-9d21-5e61-9a23-38ca4ee63b7b
DOI
10.20944/preprints202210.0289.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Future of Targeted Treatment of Primary Sjögren's Syndrome: A Focus on Extra-Glandular PathologyDOI 10.20944/preprints202210.0289.v1
Select a neighboring publication to make it the new centre.